Tag: Multiple Sclerosis
Fingolimod Cuts Multiple Sclerosis Relapses in Pediatric Patients
Compared with interferon beta-1a, less lesion accumulation seen on MRI but more adverse events
Ibudilast Appears to Slow Brain Atrophy Progression in MS
In phase 2 randomized trial, 2.5 ml less brain-tissue loss with ibudilast than with placebo over 96 weeks
Organic Solvents + Genetics May Increase Risk of Multiple Sclerosis
Finding of susceptibility seen regardless of smoking status
Dynamics of Brain Volume Loss Vary With MS Progression
Limited reproducibility of estimates seen using different imaging methods
Various Clinical Disturbances Precede MS Diagnosis
Understanding prodromal signs may improve multiple sclerosis identification
FDA Expands Use of MS Drug to Include Children
Gilenya is the first multiple sclerosis drug approved for children
Guidelines Developed for Use of Drugs in Multiple Sclerosis
Guidelines relate to starting, switching, stopping disease-modifying therapies
Siponimod Cuts Risk of Disability Progression in Multiple Sclerosis
Reduction in 3-month confirmed disability progression in secondary progressive multiple sclerosis
Higher Sun Exposure Tied to Lower Risk of Multiple Sclerosis
Findings based on sun exposure at 5 to 15 years of age and at 5 to 15 years before MS onset
AAN: High Fish Intake Linked to Reduced Risk of Multiple Sclerosis
Two tag SNPs in fatty acid desaturase gene 2 independently linked to reduced risk of MS
